Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Manu Chakravarthy"'
Autor:
Xiaohua Douglas Zhang, David Pechter, Liming Yang, Xiaoli Ping, Zuliang Yao, Rumin Zhang, Xiaolan Shen, Nina Xiaoyan Li, Jonathan Connick, Andrea R Nawrocki, Manu Chakravarthy, Cai Li
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0182810 (2017)
Continuous glucose monitoring (CGM) is a platform to measure blood glucose (BG) levels continuously in real time with high enough resolution to document their underlying fluctuations. Multiscale entropy (MSE) analysis has been proposed as a measure o
Externí odkaz:
https://doaj.org/article/6489e2210c37412d95edd758b0e72270
Publikováno v:
Endocrinol Diabetes Metab
Cover caption The cover image, designed and illustrated by Shalini Prasad, DeSha Creative (https://www.de.shacreative.net), is based on the Review Article The Metabolic Basis of Nonalcoholic Steatohepatitis (NASH) by Chakravarthy and Tetri, https://d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fd7369b7166e5cad565b67eaa8221d
https://europepmc.org/articles/PMC7576302/
https://europepmc.org/articles/PMC7576302/
Autor:
Maria P. Martinez-Cantarin, Walter K. Kraft, Deborah Panebianco, Rebecca E Wrishko, Ka Lai Yee, Eric Mangin, Wen Liu, Jacqueline B. McCrea, Manu Chakravarthy
Publikováno v:
Clin Drug Investig
BACKGROUND AND OBJECTIVES: Suvorexant is an orexin receptor antagonist indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. As suvorexant is metabolized primarily by Cytochrome P450 3A (CYP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096ce6a3cc015e7a248ed2aa0e80852c
https://europepmc.org/articles/PMC6929321/
https://europepmc.org/articles/PMC6929321/
Autor:
Chengcheng Liu, Maria Gutierrez, Christine Brandquist, S. Aubrey Stoch, Deborah Panebianco, Kate Mostoller, Jacqueline B. McCrea, Stefan Zajic, Chantal Mahon, Manu Chakravarthy, Fang Liu
Publikováno v:
Clinical pharmacology in drug developmentReferences. 8(7)
Assessing risk for QTc interval prolongation in a thorough QTc study is a standard recommendation when evaluating new chemical entities. As part of the clinical development program for odanacatib, an oral selective inhibitor of cathepsin K previously
Autor:
Rebecca E. Wrishko, Jacqueline B. McCrea, Ka Lai Yee, Wen Liu, Deborah Panebianco, Eric Mangin, Manu Chakravarthy, Maria P. Martinez-Cantarin, Walter K. Kraft
Publikováno v:
Clinical Drug Investigation. 39:453-454
Autor:
Jan de Hoon, Michael Klimas, Manu Chakravarthy, Christophe Deroose, Ruben Declercq, Inge De Lepeleire, Corinne Vandermeulen, Andrey Postnov, Justin Dennie, Olivier Gheysens, Koen Van Laere, Lori A. Mixson
Publikováno v:
Journal of Nuclear Medicine. 56:1520-1526
The quantification and variability of skeletal muscle glucose utilization (SMGU) in healthy subjects under basal (low insulin) conditions are poorly known. This information is essential early in clinical drug development to effectively interrogate no
Autor:
Dan Xie, Liangsu Wang, Brenno Astiarraga, Monica Nannipieri, Rebecca A. Haeusler, Jose Castro-Perez, Stefania Camastra, Manu Chakravarthy, Ele Ferrannini
Publikováno v:
Diabetes
Biliopancreatic diversion (BPD) improves insulin sensitivity and decreases serum cholesterol out of proportion with weight loss. Mechanisms of these effects are unknown. One set of proposed contributors to metabolic improvements after bariatric surge
Autor:
Yuval A. Patel, Joanne C. Imperial, Andrew J. Muir, Quentin M. Anstee, David DeBrota, Lara Dimick-Santos, Claudia Filozof, Ruby Mehta, Arun J. Sanyal, Elmer Schabel, Brent A. Neuschwander-Tetri, Veronica Miller, Sander Bangma, Melanie Baxter, Sherif Boulos, Gary Burgess, Manu Chakravarthy, Rose Christian, Anthony Coombs, Goran Gannedahl, Richard Herrmann, Dean Hum, Joanne Imperial, Stuart Kendrick, Leigh MacConell, Sophie Megnien, Andrew Muir, Yuval Patel, Dan Peres, Stephen Rossi, Arun Sanyal, David Shapiro, Tim St Pierre, Michael Zemel
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease worldwide and is an increasing cause of liver-related morbidity and mortality. Nonalcoholic steatohepatitis (NASH), the progressive histological subtype of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c0e8b8f543a51c1159349167e1f477
https://europepmc.org/articles/PMC5861348/
https://europepmc.org/articles/PMC5861348/
Autor:
David Pechter, Xiaolan Shen, Xiaoli Ping, Nina Xiaoyan Li, Cai Li, Rumin Zhang, Andrea R. Nawrocki, Xiaohua Douglas Zhang, Jonathan Connick, Liming Yang, Zuliang Yao, Manu Chakravarthy
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0182810 (2017)
PLoS ONE
PLoS ONE
Continuous glucose monitoring (CGM) is a platform to measure blood glucose (BG) levels continuously in real time with high enough resolution to document their underlying fluctuations. Multiscale entropy (MSE) analysis has been proposed as a measure o
Autor:
N. Manu Chakravarthy
Publikováno v:
India and the Unthinkable: Backwaters Collective on Metaphysics and Politics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d4b7b83913200bf856b4e1eff9b7ba3
https://doi.org/10.1093/acprof:oso/9780199466863.003.0006
https://doi.org/10.1093/acprof:oso/9780199466863.003.0006